The price of one dose of durvalumab/Infinifer

Durvalumab/Infinifer (Durvalumab) is an immune checkpoint inhibitor, an anti-PD-L1 monoclonal antibody, used to enhance the patient's own immune system's ability to attack tumors. The drug has been officially approved for marketing in China and is used to treat a variety of malignant tumors, including locally advanced unresectable non-small cell lung cancer and urothelial cancer. However, it has not yet been included in the national medical insurance catalog, so patients need to purchase it at their own expense. Common domestic specifications include 120mg/2.4mL and 500mg/10mL. Each box may be sold for more than 4,000 yuan, sometimes as high as 10,000 yuan. The price is greatly affected by specifications, procurement channels and hospital pricing policies.

In overseas markets, the generic drug durvalumab has been widely supplied. The common specifications are120mg/2.4mL. Each box sells for about more than a thousand US dollars. The specific amount varies with exchange rate fluctuations. There are currently no generic versions of this drug on the market, so patients at home and abroad rely on the original product. As a PD-L1 inhibitor, durvalumab relieves the inhibitory effect of the tumor microenvironment on T cells, allowing the body's immune system to re-recognize and attack tumor cells, thereby improving disease prognosis. Although the price is higher, its clinical value in specific indications is recognized by international guidelines.

During use, patients should purchase it through regular channels and perform intravenous infusion under the guidance of a doctor. At the same time, they should pay attention to drug safety, allergic reactions and potential immune-related adverse events. Overall, durvalumab has limited accessibility in the domestic market, but its role in the field of immunotherapy is gradually emerging, providing new treatment options for patients with specific tumors. At the same time, the difference between overseas prices and domestic selling prices also reflects the cost structure and policy impact of imported drugs in the domestic circulation.

Reference materials:https://www.imfinzi.com/